Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
2seventy bio, Inc. - Common Stock
(NQ:
TSVT
)
4.430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about 2seventy bio, Inc. - Common Stock
< Previous
1
2
3
4
Next >
2 Growth Stocks That Could Rocket Higher Before the End of 2023
October 08, 2023
Potential approvals of new medicines expected soon could push these stocks through the roof.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
The Latest Analyst Ratings for 2seventy bio
September 12, 2023
Via
Benzinga
Analyst Expectations for 2seventy bio's Future
August 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy
September 16, 2023
Hasten Biopharma entered a $325 million agreement for greater China rights to a PCSK9 inhibitor from LIB Therapeutics. Meanwhile, Insilico Medicine out-licensed global rights to a small molecule...
Via
Talk Markets
Where 2seventy bio Stands With Analysts
July 28, 2023
Via
Benzinga
2seventy bio: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
2seventy bio's Return On Capital Employed Overview
March 20, 2023
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
2seventy Bio's Cost Cuts Prudent But Analyst Says It Induces Lower Confidence In Lead Product
September 13, 2023
Guggenheim Partners downgraded 2seventy Bio Inc (NASDAQ: TSVT) to Neutral from Buy and
Via
Benzinga
Around $3.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
August 17, 2023
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
Via
Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
August 15, 2023
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 09, 2023
On Wednesday, 155 companies set new 52-week lows.
Via
Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 02, 2023
During Wednesday's trading, 103 companies set new 52-week lows.
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
June 20, 2023
The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for
Via
Benzinga
Cancer Drug Trials Put On Hold After Patients Died
June 17, 2023
Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
2seventy Bio Pauses Pediatric Blood Cancer Trial After Patient Death, Stock Plunges
June 14, 2023
2seventy Bio Inc (NASDAQ: TSVT) announced that the Phase 1 trial of the PLAT-08 study of SC-DARIC33 in Acute Myeloid Leukemia (AML), has been paused by Seattle Children's, the company's partner and...
Via
Benzinga
2seventy Bio Stock Crumbles After A Patient Dies In Its Pediatric Cancer Study
June 14, 2023
The company is investigating whether the death is tied to the experimental drug.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
July 28, 2023
Via
Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND
May 12, 2023
Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter.
Via
Benzinga
Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit
April 19, 2023
The company could have the best-in-class CAR-T drug for multiple myeloma patients.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 21, 2023
During Friday's session, 149 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.